CUSIP: 65481J109
What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 65481J109:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2017 Q3 | 0 | $0 | -$20,919,000 | 0 | |
| 2017 Q2 | 8,693,578 | $20,948,000 | +$896,160 | $2.41 | 24 |
| 2017 Q1 | 8,286,462 | $24,195,000 | -$3,073,520 | $2.92 | 27 |
| 2016 Q4 | 9,970,764 | $22,334,000 | -$20,212,829 | $2.24 | 38 |
| 2016 Q3 | 12,317,427 | $100,138,000 | -$1,826,903 | $8.13 | 50 |
| 2016 Q2 | 12,622,689 | $58,063,000 | -$1,375,903 | $4.60 | 44 |
| 2016 Q1 | 13,312,256 | $55,509,000 | -$1,288,185 | $4.17 | 57 |
| 2015 Q4 | 13,352,815 | $103,355,313 | -$4,837,419 | $7.74 | 57 |
| 2015 Q3 | 13,352,556 | $173,047,101 | +$14,492,079 | $12.97 | 61 |
| 2015 Q2 | 12,134,560 | $183,183,000 | +$183,183,004 | $15.15 | 42 |